Skip to content

Quest Diagnostics, Inc.

United StatesFDA applicant, unverified

Devices
7

What Quest Diagnostics, Inc. makes

The company develops and provides diagnostic tests for detecting drug metabolites in hair and urine samples, including immunoassays for cocaine, THC, methamphetamine, opiates, and amphetamines. These tests are designed for clinical and forensic use to identify substance use patterns over extended periods. The portfolio includes hair analysis kits for multiple substances and enzyme-linked immunosorbent assays (EIA) for urine-based testing.

The devices fall under FDA Class II and Unclassified (U) regulatory categories, with some listed via the 510(k) premarket notification process. They are registered in the FDA’s 510(k) database. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue7

Newest first, rows 1-7 of 7

Frequently asked questions

How many devices does Quest Diagnostics, Inc. have in the registry?

The registry currently lists 7 devices for Quest Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Quest Diagnostics, Inc.'s devices?

Among its 7 most recently registered devices, Quest Diagnostics, Inc. has devices listed in FDA 510(k) (7 devices).

What risk classes do Quest Diagnostics, Inc.'s devices fall under?

Among its 7 most recently registered devices, the classes recorded for Quest Diagnostics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Quest Diagnostics, Inc. in the registry?

The most recently registered devices listed for Quest Diagnostics, Inc. include QUEST DIAGNOSTICS HAIRCHECK-DT (PCP, QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA, QUEST DIAGNOSTICS HAIRCHECK-DT (THC) and QUEST DIAGNOSTICS METHAMPHETAMINE MICRO-PLATE EIA.

Generated automatically from registry data and not verified by a human reviewer.